ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 63 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $360,159 | +1643.1% | 282,478 | +624.6% | 0.00% | – |
Q4 2022 | $20,662 | -55.1% | 38,984 | -38.3% | 0.00% | – |
Q3 2022 | $46,000 | -64.6% | 63,215 | -0.2% | 0.00% | – |
Q1 2022 | $130,000 | -54.7% | 63,346 | -36.5% | 0.00% | – |
Q4 2021 | $287,000 | -60.2% | 99,705 | -41.4% | 0.00% | – |
Q3 2021 | $721,000 | +41.1% | 170,184 | +76.5% | 0.00% | – |
Q2 2021 | $511,000 | -36.9% | 96,399 | -44.6% | 0.00% | – |
Q1 2021 | $810,000 | +73.8% | 174,131 | +26.0% | 0.00% | – |
Q2 2020 | $466,000 | +441.9% | 138,145 | +1116.9% | 0.00% | – |
Q3 2019 | $86,000 | -64.8% | 11,352 | -37.0% | 0.00% | – |
Q2 2019 | $244,000 | +577.8% | 18,005 | +46.8% | 0.00% | – |
Q4 2018 | $36,000 | -87.6% | 12,267 | -65.5% | 0.00% | -100.0% |
Q3 2018 | $290,000 | +21.3% | 35,555 | +44.6% | 0.00% | 0.0% |
Q2 2018 | $239,000 | – | 24,588 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ETF MANAGERS GROUP, LLC | 2,679,457 | $20,257,000 | 0.73% |
Portolan Capital Management | 777,293 | $5,876,000 | 0.66% |
CAMPBELL CAPITAL MANAGEMENT INC | 110,451 | $835,000 | 0.62% |
ZEKE CAPITAL ADVISORS, LLC | 402,212 | $3,041,000 | 0.27% |
Leap Investments LP | 46,084 | $348,000 | 0.17% |
Bernardo Wealth Planning LLC | 26,419 | $199,000 | 0.14% |
Claraphi Advisory Network, LLC | 14,744 | $111,000 | 0.07% |
Sterling Investment Advisors, Ltd. | 11,000 | $83,000 | 0.04% |
A.R.T. Advisors, LLC | 81,372 | $615,000 | 0.03% |
Mirae Asset Global Investments Co., Ltd. | 544,408 | $4,116,000 | 0.03% |